Literature DB >> 16282472

The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes.

Wolfgang Resch1, Bernard Moss.   

Abstract

We provide the initial characterization of the product of the vaccinia virus L3L open reading frame (VACWR090), which is conserved in all sequenced members of the poxvirus family. The predicted polypeptide contains no motifs or other features that provided a clue to the role of the L3 protein, and no functional information was available regarding a homolog discovered in Plasmodium falciparum. The L3 protein was expressed following viral DNA replication, a finding consistent with a putative late promoter sequence, and was packaged as a non-membrane protein in mature virus particles. A recombinant virus, in which the L3L gene was regulated by the Escherichia coli lac operator/repressor system, had a conditional lethal phenotype. The virus replicated in the presence of inducer, but in its absence, the yields of infectious virus were reduced by 99%. When cells were infected without inducer, however, no defect in gene expression or morphogenesis was noted. Virus particles lacking L3, which assembled in the absence of inducer, were indistinguishable from wild-type virions with regard to morphology, major structural proteins, and DNA content but were noninfectious. L3-deficient virions were able to bind and penetrate cells but produced extremely small amounts of viral early mRNA. A defect in transcription was demonstrated by in vitro studies with permeabilized virions, but soluble extracts of L3-deficient virions showed normal levels of template-dependent transcriptional activity, indicating that only transcription of the packaged genome is impaired.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282472      PMCID: PMC1287552          DOI: 10.1128/JVI.79.23.14719-14729.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

3.  Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome.

Authors:  Chris Upton; Stephanie Slack; Arwen L Hunter; Angelika Ehlers; Rachel L Roper
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

4.  DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.

Authors:  J W Hooper; D M Custer; C S Schmaljohn; A L Schmaljohn
Journal:  Virology       Date:  2000-01-20       Impact factor: 3.616

5.  Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion.

Authors:  Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.

Authors:  Flavio Da Fonseca; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

Review 7.  Vaccinia virus transcription.

Authors:  Steven S Broyles
Journal:  J Gen Virol       Date:  2003-09       Impact factor: 3.891

8.  Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.

Authors:  E Katz; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

9.  Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway.

Authors:  Tatiana G Senkevich; Brian M Ward; Bernard Moss
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene.

Authors:  Tatiana G Senkevich; Brian M Ward; Bernard Moss
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more
  9 in total

1.  Structure/Function analysis of the vaccinia virus F18 phosphoprotein, an abundant core component required for virion maturation and infectivity.

Authors:  Nadi T Wickramasekera; Paula Traktman
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

2.  A novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes.

Authors:  Jason P Laliberte; Bernard Moss
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Temperature-sensitive mutant in the vaccinia virus E6 protein produce virions that are transcriptionally inactive.

Authors:  Olga Boyd; Audra L Strahl; Carson Rodeffer; Richard C Condit; Nissin Moussatche
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

4.  Interactions of the vaccinia virus A19 protein.

Authors:  P S Satheshkumar; L Renee Olano; Carl H Hammer; Ming Zhao; Bernard Moss
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

5.  Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization.

Authors:  Nissin Moussatche; Richard C Condit
Journal:  Virology       Date:  2014-12-08       Impact factor: 3.616

6.  Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Eva Pérez-Jiménez; Juan Carlos Oliveros; Mariano Esteban
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

7.  The vaccinia virus E8R gene product is required for formation of transcriptionally active virions.

Authors:  Sayuri E M Kato; Richard C Condit; Nissin Moussatché
Journal:  Virology       Date:  2007-07-09       Impact factor: 3.616

8.  Vaccinia virions deficient in transcription enzymes lack a nucleocapsid.

Authors:  Baron D H McFadden; Nissin Moussatche; Karen Kelley; Byung-Ho Kang; Richard C Condit
Journal:  Virology       Date:  2012-09-01       Impact factor: 3.616

9.  Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA.

Authors:  Maite Ramírez; Saritza Santos; Osmarie Martínez; Ricardo Rodríguez; Eric Miranda; Willy D Ramos-Perez; Miguel Otero
Journal:  Vaccine       Date:  2018-03-07       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.